Trial intelligence / Profile preview

Randomized study of combined diuretics in hemodialysis patients with residual renal function

2013-003214-41Phase 4Completed

Sponsor
Fundació Parc Taulí
Start
Sep 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in chronic kidney disease (CKD) comparing Furosemide + hydrochlorothiazide with Comparator/standard of care (2 arms). Primary endpoint: Interdialytic weight gain in long days at the end of each period. Started Sep 2013; status: completed.

02

Drugs

furosemidehydrochlorothiazide
03

Conditions

chronic kidney disease (CKD)

Beyond the preview

Go deeper on 2013-003214-41.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-003214-41.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call